Consumer Insights
Uncover trends and behaviors shaping consumer choices today
Procurement Insights
Optimize your sourcing strategy with key market data
Industry Stats
Stay ahead with the latest trends and market analysis.
Explore Our Diverse Range Of Offerings
From detailed reports to experts services offered in 15+
Industry Domains
Add 2 More Reports For 20% off
Report Overview
The substance drug abuse market was valued at USD 8.47 Billion in 2025, driven by the rising incidence of substance abuse across the 8 major markets. The market is expected to grow at a CAGR of 5.10% during the forecast period of 2026-2035, with the values likely to reach USD 13.93 Billion by 2035.
Q1 2026 Market Updates
Geopolitical Impact of Iran, US, and Israel War on the Substance Drug Abuse Market
United States: The Substance Drug Abuse Market, a key segment of the global economy, is experiencing a complex operating environment in Q1 2026 as a direct consequence of the US-Israel-Iran war. Petrochemical-derived pharmaceutical packaging materials including blister packs, polymer bottles, and specialty film coatings are facing 15-20% cost inflation from the Gulf supply disruption. API production costs are rising as petrochemical reagent prices increase 15-20%. Air freight costs have spiked dramatically, with temperature-sensitive pharmaceutical distribution facing elevated costs and extended lead times as Gulf carrier networks remain suspended. Consumer spending caution is growing as gasoline above USD 4 per gallon and 4.2% projected inflation compress household discretionary budgets. Clinical trial operations in Middle Eastern investigator sites have been disrupted, and medical supply chains face elevated logistics costs.
Iran: Iran's healthcare system has been severely damaged by the conflict, with the WHO identifying at least 13 health facilities as conflict-damaged. The domestic pharmaceutical and medical device sector, already severely constrained by sanctions limiting access to Western medical technology and APIs, has been further disrupted by power outages, workforce displacement, and the collapse of medical supply chain logistics. Iranian patients requiring treatment for substance drug abuse conditions face an acute access crisis, as hospital operations are redirected toward treating conflict casualties and basic medical supplies are running low.
Israel: Israel's pharmaceutical and medical device sector is operating under emergency conditions. Israeli hospitals have moved some operations underground, medical resources are being prioritised for conflict casualties, and elective and non-emergency healthcare consumption has declined. However, Israel's biopharmaceutical research base continues to operate, with several Israeli companies involved in novel treatment development for substance drug abuse indications. Post-conflict, Israel's healthcare system is expected to invest significantly in medical technology and pharmaceutical infrastructure restoration and capacity expansion.
Key Takeaways
Government
- Relevant health authorities should activate emergency pharmaceutical supply chain resilience protocols, ensuring that API and packaging material sourcing for essential substance drug abuse treatments is not concentrated in Gulf-adjacent supply chains exposed to maritime disruption.
- Regulatory agencies should fast-track review of treatment availability and consider emergency compassionate use extensions for patients in conflict-affected regions who face interruption to their standard of care.
- Governments should monitor petrochemical-derived pharmaceutical packaging cost inflation, ensuring that price increases remain within access thresholds for patients requiring ongoing substance drug abuse treatment.
Market
- Petrochemical-derived pharmaceutical packaging and API precursor costs are rising 15-20%, creating margin compression for substance drug abuse manufacturers in the near term, with limited ability to pass costs through in price-regulated markets.
- The conflict's disruption to clinical trial infrastructure in Middle Eastern sites may modestly delay regulatory submissions and new treatment launches that had enrolled patients from the region, though the structural market growth trajectory remains intact.
- Healthcare system demand for substance drug abuse treatment is fundamentally driven by disease burden and demographics rather than geopolitical events, providing strong structural insulation for the market's long-term growth trajectory.
Procurement
- Pharmaceutical procurement teams should build 90-day safety stock for essential substance drug abuse treatment drugs and biological agents, hedging against further pharmaceutical logistics cost increases and potential supply disruptions.
- API and excipient buyers should review single-source supplier risks for Gulf-adjacent petrochemical-derived pharmaceutical inputs, establishing secondary supply arrangements with non-Gulf origin manufacturers in India, China, and Europe.
- Hospital pharmacy procurement managers should review cold-chain logistics contracts for temperature-sensitive substance drug abuse therapeutics, ensuring that alternative air routing through non-conflict-zone hubs is available if Gulf carrier services remain suspended.
2025
Base Year
2019-2025
Historical Period
2026-2035
Forecast Period
-
The market for substance drug abuse is driven by the rising incidences of substance abuse, propelled by stress and anxiety, peer pressure, and mental health issues among the general public.
-
The rising introduction of grant fund opportunities directed at promoting the development of solutions that enhance the treatment, diagnosis, or monitoring of people affected by substance use disorder and addiction is expected to boost market growth in the coming years.
-
The increasing use of mobile health apps to manage drug addiction issues is a significant market trend.
Compound Annual Growth Rate
5.1%
Value in USD Billion
2026-2035
*this image is indicative*
Substance Drug Abuse Market Overview
Substance abuse or drug abuse refers to the excessive use of psychoactive drugs like pain medications, alcohol, or illegal drugs which can result in emotional, physical, and social harm to an individual. Alcohol is reported as the most commonly used drug by Americans, followed by tobacco and marijuana. In the United States, 1 in 4 people over the age of 12 admitted to the use of illicit drugs. The market for substance drug abuse is driven by the rising incidences of substance abuse, propelled by stress and anxiety, peer pressure, and mental health issues among the general public. The rise in government policies and initiatives that work towards reducing drug abuse and raising awareness about the dangers of addiction are expected to fuel market growth. Moreover, the expansion of treatment options, growth in telemedicine services, and the increasing adoption of digital health technologies are anticipated to shape the market dynamics.
Substance Drug Abuse Market Growth Drivers
Increasing Incidence of Substance Abuse is Driving Market Growth
Drug and substance abuse poses a major problem in the United States. According to the recent National Survey on Drug Use, 70 million Americans accounting for 25% of the population admitted to using illicit drugs such as cocaine, heroin, and methamphetamines. The survey also revealed that 48.7 million individuals in the United States struggle with substance abuse. The rising incidence of substance abuse, driven by factors such as stress, peer pressure, and mental health issues, is contributing to the market growth.
Substance Drug Abuse Market Trends
The market is witnessing several trends and developments to improve the current scenario. Some of the notable trends are as follows:
Substance Drug Abuse Market Segmentation
The market report offers a detailed analysis of the market based on the following segments:
Market Breakup by Treatment Type
- Drugs
- Methadone
- Buprenorphine
- Naltrexone
- Others
- Counselling & Behavioral Therapy
- Others
Market Breakup by Route of Administration
- Oral
- Parenteral
- Others
Market Breakup by End User
- Hospitals & Clinics
- Rehabilitation Centers
- Homecare Settings
- Others
Market Breakup by Region
- United States
- EU-4 and the United Kingdom
- Germany
- France
- Italy
- Spain
- United Kingdom
- Japan
- India
Substance Drug Abuse Market Share
Treatment Segment is Anticipated to Witness Substantial Growth
The market segmentation based on treatment includes drugs (methadone, buprenorphine, naltrexone, and others), as well as counseling and behavioral therapy, among others. The drug segment helps in managing withdrawal symptoms and cravings. Methadone is commonly used to treat opioid addiction and is also included in government-supported treatment programs due to its established efficacy. Counseling and behavioral therapies also play a significant role in addiction treatment. The growing demand for virtual counseling services, particularly through telehealth platforms, is poised to aid the growth of the treatment segment in the forecast period.
Purchase the Regional Overview for USD 1099
If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.
Purchase the Regional Overview for USD 1099
If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.
Purchase the Regional Overview for USD 1099
If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.
Substance Drug Abuse Market Analysis by Region
The market segmentation by region includes the United States, EU-4 (Germany, France, Italy, Spain), the United Kingdom, Japan, and India. The United States dominates the market share owing to the increased legalization of cannabis and the growing public awareness about mental health issues. Increased government initiatives such as the establishment of the Substance Abuse and Mental Health Services Administration (SAMHSA), an agency that operates within the U.S. Department of Health and Human Services, work towards enhancing behavioral health in the country including services that improve the accessibility of substance use and mental disorder information. Additionally, the expansion of telehealth services and the rising emphasis on prescription drug abuse are likely to support the market growth.
Leading Players in the Substance Drug Abuse Market
The key features of the market report comprise patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, and strategic initiatives by the leading key players. The major companies in the market are as follows:
Pfizer Inc.
Pfizer, headquartered in New York, United States, plays a significant role in the growth of the market. Pfizer manufactures Naloxone Hydrochloride Injection, USP, a pure opioid antagonist that can prevent or reverse the effects of opioids such as sedation, hypotension, and respiratory depression.
Mallinckrodt Pharmaceuticals
Mallinckrodt Pharmaceuticals, based in Staines-upon-Thames, United Kingdom, is a leading manufacturer of generic medications, specialty drugs, and imaging agents. The company manufactures methadone products including Methadone hydrochloride tablets that are prescribed to manage opioid addiction in maintenance or detoxification programs.
Rosemont Pharmaceuticals Limited
United Kingdom-based Rosemont Pharmaceuticals has a prominent presence in the market, known for its novel-delivery, patient-centered medications. The company specializes in the manufacturing of oral liquid medicine across a range of therapeutic areas including medications for substance abuse treatment like methadone and buprenorphine. Methadone Hydrochloride SF Oral Solution is one of the key medications of Rosemont indicated for the treatment of drug addiction or as a narcotic abstinence syndrome suppressant.
Spectrum Chemicals
Spectrum Chemical is one of the leading players in the market, recognized as a global provider of quality chemicals and laboratory equipment, among others. The company sells Methadone Hydrochloride (CII), USP which is a synthetic opioid with analgesic activity.
*Please note that this is only a partial list; the complete list of key players is available in the full report. Additionally, the list of key players can be customized to better suit your needs.*
Other key players in the market include Taj Pharmaceuticals Limited, VistaPharm LLC, Teva Pharmaceuticals Inc., Hikma Pharmaceutical PLC, Braeburn Inc., and Atlas Medical GmbH.
Key Questions Answered in the Substance Drug Abuse Market Report
- What was the substance drug abuse market value in 2025?
- What is the substance drug abuse market forecast outlook for 2026-2035?
- What are the regional markets covered in the EMR report?
- What is market segmentation based on treatment?
- What is the market breakup based on the route of administration?
- Who are the major end users in the market?
- What is the market breakup by distribution channels?
- What are the major factors aiding the substance drug abuse market demand?
- How has the market performed so far and how is it anticipated to perform in the coming years?
- What are the market's major drivers, opportunities, and restraints?
- Which regional market is expected to lead the market share in the forecast period?
- Which country is expected to experience expedited growth during the forecast period?
- How does the rising burden of substance abuse disorders affect the market landscape?
- What are the major substance drug abuse market trends?
- How does the growing awareness about substance abuse impact the market size?
- Which treatment will dominate the market share?
- Which route of administration is expected to have a high market value in the coming years?
- Which end user will experience the highest demand in the market segment?
- Which distribution channel is projected to contribute to the highest market growth?
- Who are the key players involved in the substance drug abuse market?
- What is the patent landscape of the market?
- What are the current unmet needs and challenges in the market?
- How are partnerships, collaborations, mergers and acquisitions among the key market players shaping the market dynamics?
Pricing Plans
Upto 15% Off
USD
-
$3299 $2969
-
$5499 $4949
-
$6999 $5949
-
$8199 $6969
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Looking for specific insights?
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
Report Summary
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
| REPORT FEATURES | DETAILS |
| Base Year | 2025 |
| Historical Period | 2019-2025 |
| Forecast Period | 2026-2035 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Treatment Type |
|
| Breakup by Route of Administration |
|
| Breakup by End User |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
Datasheet
One User
USD 3,299
USD 2,969
tax inclusive*
- Selected Segments
- Printing Restrictions
- Excel Spreadsheet Delivered via Email
- Full Report
- Periodic Updates
- Post Sales Analysts Support
- Unlimited Prints
Single User License
One User
USD 5,499
USD 4,949
tax inclusive*
- All Segments
- Printing Restrictions
- PDF Delivered via Email
- Custom Report Layout
- Post Sales Analysts Support
- Periodic Updates
- Unlimited Prints
Five User License
Five User
USD 6,999
USD 5,949
tax inclusive*
- All Segments
- Five Prints Available
- PDF Delivered via Email
- Limited Free Customization
- Post Sales Analyst Support
- Custom Report Layout
- Periodic Updates
- Unlimited Prints
Corporate License
Unlimited Users
USD 8,199
USD 6,969
tax inclusive*
- All Segments
- Unlimited Prints Available
- PDF & Excel Delivery via Email
- Limited Free Customization
- Post Sales Analysts Support
- Discount On Next Update
- Custom Report Layout
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Bundle Type
Flash Bundle
20% OFF
Number of Reports: 3
Small Business Bundle
25% OFF
Number of Reports: 5
Growth Bundle
30% OFF
Number of Reports: 8
Enterprise Bundle
35% OFF
Number of Reports: 10
Overview
- Life Time Access
- Analyst Support Related to Report
- PDF Version of the Report
- Complimentary Excel Data Set
- Free Analyst Hours
- Complimentary Free 1 Month Subscription to Trade Data Base
- Complimentary One Month Subscription to Price Database (Chemicals only)
- Complimentary PPT Version of the Report
- Complimentary License Upgrade
- Complimentary Power BI Dashboards
- Life Time Access
- Analyst Support Related to Report
- PDF Version of the Report
- Complimentary Excel Data Set
- Free Analyst Hours - 50 Hours
- Complimentary Free 1 Month Subscription to Trade Data Base
- Complimentary One Month Subscription to Price Database (Chemicals only)
- Complimentary PPT Version of the Report
- Complimentary License Upgrade
- Complimentary Power BI Dashboards
- Life Time Access
- Analyst Support Related to Report
- PDF Version of the Report
- Complimentary Excel Data Set
- Free Analyst Hours - 80 Hours
- Complimentary Free 1 Month Subscription to Trade Data Base
- Complimentary One Month Subscription to Price Database (Chemicals only)
- Complimentary PPT Version of the Report
- Complimentary License Upgrade
- Complimentary Power BI Dashboards
- Life Time Access
- Analyst Support Related to Report
- PDF Version of the Report
- Complimentary Excel Data Set
- Free Analyst Hours - 100 Hours
- Complimentary Free 1 Month Subscription to Trade Data Base
- Complimentary One Month Subscription to Price Database (Chemicals only)
- Complimentary PPT Version of the Report
- Complimentary License Upgrade
- Complimentary Power BI Dashboards
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
- 3 Reports Included
- Life Time Acess
- Analyst Support Related to Report
- PDF Version of the Report
- Free 1 Month Subscription to Trade Data Base
- 1 Month Subscription to Price Database (Chemicals only)
- Complimentary Excel Data Set
- PPT Version of the Report
- Power BI Dashboards
- License Upgrade
- Free Analyst Hours
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
- 5 Reports Included
- Life Time Acess
- Analyst Support Related to Report
- PDF Version of the Report
- Complimentary Excel Data Set
- Free Analyst Hours - 50 Hours
- Free 1 Month Subscription to Trade Data Base
- 1 Month Subscription to Price Database (Chemicals only)
- Complimentary Excel Data Set
- PPT Version of the Report
- Power BI Dashboards
- License Upgrade
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
- 8 Reports Included
- Life Time Acess
- Analyst Support Related to Report
- PDF Version of the Report
- Complimentary Excel Data Set
- Free Analyst Hours - 50 Hours
- Free 1 Month Subscription to Trade Data Base
- 1 Month Subscription to Price Database (Chemicals only)
- License Upgrade
- Free Analyst Hours - 80 Hours
- Power BI Dashboards
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
- 10 Reports Included
- Life Time Acess
- Analyst Support Related to Report
- PDF Version of the Report
- Complimentary Excel Data Set
- Free Analyst Hours - 50 Hours
- Free 1 Month Subscription to Trade Data Base
- 1 Month Subscription to Price Database (Chemicals only)
- License Upgrade
- Power BI Dashboards
- Free Analyst Hours - 100 Hours
How To Order
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Strategic Solutions for Informed Decision-Making
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Share